The Latest Cardiac and Vascular News
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. REGULATED INFORMATION – INSIDE INFORMATION LIÈGE, Belgium, March 31, 2022 (GLOBE NEWSWIRE) — Hyloris Pharmaceuticals SA (Euronext Brussels: […]
WARRINGTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the fourth quarter and year ended December 31, 2021 and provided key business updates. “This past quarter […]
Phase 3 registrational trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) ongoing Mavacamten granted breakthrough therapy designation in China for the treatment of patients with oHCM Infigratinib approved under special named patient program for the treatment of cholangiocarcinoma (CCA) in the Bo’Ao pilot zone of Hainan […]
Initiated IMPAHCT, a global Phase 2b/Phase 3 trial of AV-101 for pulmonary arterial hypertension (PAH) in December 2021 Received FDA guidance in April 2021 that our Phase 2b/Phase 3 trial could support an NDA submission based on change in six minute walk distance as the primary endpoint for the Phase […]
CARLSBAD, Calif., March 30, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourth quarter and full year ended December 31, 2021. Recent Highlights: Reported revenue […]
FRANKLIN LAKES, N.J., March 30, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company today announced the early results and pricing terms of Morgan Stanley & Co. LLC’s (“Morgan Stanley”) previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) for the notes set […]
Award will help further improve innovative tracking service, travel app Richmond, Va. | March 25, 2022 04:06 PM Eastern Daylight Time S.L. Gimbel Foundation, a component fund at the Inland Empire Community Foundation, recently awarded United Network for Organ Sharing (UNOS) an $836,208 grant to support two innovative tools: the UNOS Organ Tracking […]
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the year ended December 31, 2021 and provided a business update. “With the advancement of our […]
SUNNYVALE, Calif., March 29, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, 2021 and filed its annual report on Form 10-K for the year ended December 31, […]
Provides enhanced credit facility up to $100 million with favorable terms and facility maturity extended to March 2027 SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced it has amended its existing […]
